Page last updated: 2024-08-25

ljc 10627 and Febrile Neutropenia

ljc 10627 has been researched along with Febrile Neutropenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jin, L; Liu, M; Rao, Q; Wang, S; Yang, Y; Zhang, J; Zhu, H	1

Other Studies

1 other study(ies) available for ljc 10627 and Febrile Neutropenia

Article	Year
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies. International journal of antimicrobial agents, 2023, Volume: 62, Issue:1 Topics: Acinetobacter Infections; Anti-Bacterial Agents; Febrile Neutropenia; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Prospective Studies	2023

Article

Year

Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies.

International journal of antimicrobial agents, 2023, Volume: 62, Issue:1

Topics: Acinetobacter Infections; Anti-Bacterial Agents; Febrile Neutropenia; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Prospective Studies

2023